However, some hospitals performed in the lowest quartile (lowest-performing 25 percent, indicating poor Safety of Care performance relative to other hospitals) of the Safety of Care measure group and still received a 5-star rating
R., Morita, T
The negative health consequences of obesity include an increased risk of a wide spectrum of diseases including type 2 diabetes (T2DM), other cardiovascular disease risk factors (e.g., hypertension and dyslipidemia), cardiovascular disease, thromboembolic events, musculoskeletal disorders, fatty liver, chronic kidney disease, certain cancers, mental health disorders, as well as sleep apnea, limited mobility, and diminished quality of life [[6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]]
A da de hoy en Espaa, est aprobado para el tratamiento de la obesidad el anlogo del receptor del GLP1 o liraglutida (ms conocido como Saxenda), as como los que inhiben la absorcin de grasas como el Xenical
Final thoughts There is no single answer to how long you should take GLP-1s
[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Singh I, et al
